155 related articles for article (PubMed ID: 37308747)
21. Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma.
Mohsen A; Taalab M; Abousamra N; Mabed M
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e606-e615. PubMed ID: 32303487
[TBL] [Abstract][Full Text] [Related]
22. Prognostic values of various hematological variables as markers of systemic inflammation in metastatic lung cancer.
Bayir D; Seber S; Yetisyigit T
J Cancer Res Ther; 2020; 16(4):731-736. PubMed ID: 32930111
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
Oncologist; 2019 Nov; 24(11):e1091-e1101. PubMed ID: 30910865
[TBL] [Abstract][Full Text] [Related]
24. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
Lv M; Wang K; Zhang Z; Zhang Z; Wan J
Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
[TBL] [Abstract][Full Text] [Related]
25. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
26. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Development of a Nomogram in Breast Cancer Patients.
Yin Y; Zhang Y; Li L; Zhang S; Liu N; Yuan S
Front Oncol; 2021; 11():650980. PubMed ID: 34976782
[TBL] [Abstract][Full Text] [Related]
27. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.
Chen L; Hao Y; Cong X; Zou M; Li S; Zhu L; Song H; Xue Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819829485. PubMed ID: 30760114
[TBL] [Abstract][Full Text] [Related]
28. Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer.
Lin JX; Wang ZK; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
J Gastrointest Surg; 2021 Feb; 25(2):387-396. PubMed ID: 32016671
[TBL] [Abstract][Full Text] [Related]
29. Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer.
Hirahara N; Matsubara T; Kaji S; Hayashi H; Sasaki Y; Kawakami K; Hyakudomi R; Yamamoto T; Tajima Y
Oncotarget; 2023 Jan; 14():71-82. PubMed ID: 36719281
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].
Niu JY; Zhu HY; Wang L; Fan L; Liang JH; Cao L; Wu W; Xia Y; Wu JZ; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):265-270. PubMed ID: 29779318
[No Abstract] [Full Text] [Related]
31. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer.
Zhou X; Du Y; Xu J; Huang Z; Qiu T; Wang X; Qian J; Zhu W; Liu P
Tumour Biol; 2014 Nov; 35(11):11659-66. PubMed ID: 25139101
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma.
Onoe S; Maeda A; Takayama Y; Fukami Y; Takahashi T; Uji M; Kaneoka Y
Med Princ Pract; 2019; 28(6):517-525. PubMed ID: 31104057
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of preoperative lymphocyte-to-monocyte ratio in gallbladder carcinoma patients and the establishment of a prognostic nomogram.
Deng Y; Xu MF; Zhang F; Yu X; Zhang XW; Sun ZG; Wang S
Medicine (Baltimore); 2020 Jul; 99(31):e21021. PubMed ID: 32756087
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
36. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
38. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
